-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
BA38017
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1333905-67-1.gif)
| Category | Hepatitis B Virus (HBV) |
| CAS | 1333905-67-1 |
| Description | BA38017 is a potent HBV core protein assembly modulator. BA38017 inhibits HBV replication with an EC50 of 0.20 μM. |
Product Information
| Synonyms | BA38017|SCHEMBL15786675|ZINC60135307|AKOS016909106|HY-145871|CS-0434323|Z898612432|N-(3-chloro-4-fluorophenyl)-2,3-dihydro-1,4-benzodioxine-5-carboxamide|1333905-67-1 |
| Molecular Weight | 307.7 |
| Molecular Formula | C15H11ClFNO3 |
| Canonical SMILES | C1COC2=C(C=CC=C2O1)C(=O)NC3=CC(=C(C=C3)F)Cl |
| Purity | >98.00% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Complexity | 384 |
| Exact Mass | 307.0411491 |
| Target | HBV |
| XLogP3-AA | 3.2 |
